MasterControl
Quality management software that keeps pharma and medtech factories audit-ready and FDA-compliant.
On the record
Checkpoint: New CEO and CFO's first full year closes, showing whether new-logo growth holds against Veeva
The call
MasterControl sits deep inside regulated workflows that are hard to rip out, while Veeva Vault QMS competes for the same accounts from an adjacent platform.
MasterControl sells software that helps pharmaceutical and medical device companies follow FDA rules and keep records that hold up in audits. The company is hard to replace because hospitals and drug makers fear losing the validated systems they already use, and switching to a different platform means retesting everything with regulators, which costs time and money. However, Veeva Vault QMS, a much larger competitor that is already inside these same companies selling other software, is now selling a similar product and has advantages because customers already know and trust Veeva. The new leadership team (with a history of selling companies) and the fact that the company's value has dropped significantly since 2022 raise questions about whether the owners will try to sell the company in the next few years, which could affect whether shareholders make good returns even if the business stays alive.
Why
01
AI pressure: Frontier LLMs (Claude, GPT) for SOP summarization and audit prep. AI can summarize documents and flag audit gaps, but liability rules keep it out of the validated system of record itself. Could AI do the core job? Unlikely.
02
Bigger players: Veeva Vault QMS. Veeva already sells a competing quality module into the same pharma and medtech accounts, bundled with its CRM and RIM tools. Could a giant copy it? No, they are blocked.
03
What protects it. FDA 21 CFR Part 11 validation and decades of embedded audit trails make ripping out the system costly and risky for regulated customers.
What would change this call
Veeva reports or is credited with new-logo QMS wins in mid-market pharma/medtech through 2026. Would show Veeva actively converting MasterControl's core customer base.
MasterControl confirms a new funding round, secondary sale, or M&A event within 12 months of new CFO's May 2026 start. Would confirm CFO's exit pedigree is being used for a liquidity or ownership event.
MasterControl's headcount trend and ARR growth rate both reported in same period through late 2026. Would clarify if shrinking headcount reflects efficiency or softening demand.
MasterControl confirms a new funding round, secondary sale, or M&A event within 12 months of new CFO's May 2026 start. Would confirm CFO's exit pedigree is being used for a liquidity or ownership event.
MasterControl's headcount trend and ARR growth rate both reported in same period through late 2026. Would clarify if shrinking headcount reflects efficiency or softening demand.
Key numbers
- $150M Series A at $1.3B valuation
- 1,200+ global customers reported
- Customers include Pfizer, Thermo Fisher, Cochlear
Named risks
- Veeva Vault QMS holds adjacent CRM, RIM, CTMS modules in same pharma accounts, a structural consolidation advantage.
- Headcount fell about 10.4% YoY through mid-2026 during a new CEO and CFO transition, cause unconfirmed.
- Secondary-market valuation estimate of ~$0.6B in July 2026 is about 54% below the December 2022 $1.3B round.
- No confirmed new funding round since December 2022 despite claimed $200M ARR and growth.
- Core AI features like document summarization could be commoditized by adjacent platform or LLM tools.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Veeva Vault QMS | contesting | Veeva already sells CRM, RIM, CTMS into same pharma accounts as of 2026, per Veeva site |
| Honeywell (TrackWise) | contesting | TrackWise, now Honeywell-owned, competes directly in eQMS market as of March 2026 |
| Hexagon (ETQ Reliance) | contesting | ETQ under Hexagon reportedly spinning off assets as Octave, reshaping QMS competition, March 2026 |
| Qualio | gaining on | Independent QMS rival with 500+ customers in 80+ countries, per March 2026 analysis |
| ComplianceQuest | contesting | Named a Gartner Magic Quadrant Leader alongside MasterControl per third-party analysis |
Questions people ask
- Is MasterControl profitable in 2026?
- MasterControl was bootstrapped and profitable for about 29 years before its first outside funding in December 2022. Post-raise profitability is not publicly disclosed, but the company reports it crossed $200M ARR around September 2025 with 33.3% YoY growth, suggesting continued scale without confirmed losses.
- Who owns MasterControl?
- MasterControl is privately held. Sixth Street Growth led its first-ever outside funding, a $150M Series A closed December 15, 2022, valuing the company at $1.3B and making it a unicorn. No further primary funding round has been publicly confirmed since.
- Could AI replace MasterControl?
- Unlikely to fully replace it. MasterControl's core value is a validated, audit-trailed FDA 21 CFR Part 11 system of record for GxP compliance, not just document processing. It has added its own AI features, including a SOP Analyzer (January 2026) and Event Summarizer (April 2026), built on an ISO 42001-certified platform.
- Who is MasterControl's biggest competitor?
- Veeva Vault QMS, part of publicly traded Veeva Systems, is MasterControl's closest rival. Veeva already sells CRM, RIM, and CTMS modules into the same pharma accounts MasterControl serves, giving it a platform-adjacency advantage as of 2026.
- What is MasterControl's revenue?
- MasterControl reportedly surpassed $200M in annual recurring revenue around September 2025, up from over $100M ARR in December 2021, per company-linked tracking site Latka, which cited 33.3% YoY growth as of November 27, 2025.
- Is MasterControl's valuation falling?
- A secondary-market estimate from TrueUp/Notice.co put MasterControl's valuation at roughly $0.6B as of July 30, 2026, about 54% below its December 2022 Series A valuation of $1.3B. This is an unconfirmed secondary-market mark, not a primary funding round.
Timeline
- 2026-05-28New CFO Wynn Clayton hired; Ian Ball promoted to Chief Sales Officer
- 2026-04-21Launched AI-powered Event Summarizer on ISO 42001-certified platform
- 2026-04-09CEO Jon Beckstrand moves to Board Chair; David Edwards named CEO
- 2026-01-27Launched AI-powered SOP Analyzer built on proprietary ADAPT AI platform
- 2025-09-30Company reportedly crossed $200M in annual recurring revenue
- 2025-03-03Acquired Qualer, a cloud-native asset-management and CMMS company
- 2025-02-18General availability of AI-powered Document Summarizer
- 2022-12-15Closed $150M Series A led by Sixth Street Growth at $1.3B valuation
- 2021-12-31Surpassed $100M ARR, growing over 25% YoY, before any outside funding
- 1993Founded as Document Control Systems in Utah
Revision history
29 July 2026
First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- MasterControl Moves Corporate HQ to Salt Lake City (2022-12-09)
- MasterControl Raises $150M Series A Funding Round from Sixth Street Growth at Valuation of $1.3B
- MasterControl Closes $150 Million Series A Funding Round (2022-12-15)
- MasterControl Stock Price, Funding, Valuation, Revenue & Financial Statements (2025-03-02)
- $200M ARR, $1.3B Valuation (2025-11-27)
- Veeva Vault Alternatives: An eQMS & GxP Feature Matrix (2026-03-14)
- MasterControl Strengthens Executive Leadership Team (2026-05-28)
- CorDx Selects MasterControl (2024-10-23)
- MasterControl Number of Employees 2026 (2026-06-29)
- MasterControl - Headcount, Funding & Open Jobs (2026-07-02)
- MasterControl Acquires Qualer (2025-03-03)
- MasterControl Announces General Availability of AI-Powered Document Summarizer (2025-02-18)